scholarly journals Artificial Intelligence for the Diagnosis and Treatment of Diabetes Kidney Disease: a systematic review

Author(s):  
Shams Mohammad Abrar

Background: Diabetic nephropathy (DN) is a serious microvascular complication that affects 40% of diabetes patients. In the last decade, artificial intelligence (AI) has been widely used in both structured and unstructured clinical data to improve the treatment of patients/potential patients with DN. Methods: This systematic review aims to cover all applications of AI in the clinical use of DN or related topics. Studies were searched in four open-access databases (Pubmed, IEEE Xplore, DBLP Computer Science Bibliography, and ACM digital library). Finally, the author manually searched the reference list of included studies in the study for additional relevant articles. Results: Finally, a total of 24 original peers reviewed articles were included in this study. Through a manual data extraction, the summary of key information such as applied AI algorithm, main outcomes, performance evaluation etc. was taken. Then the included studies underwent a quality assessment criterion, assessing the reproducibility, generalizability etc. Most of the included studies revealed that the AI frameworks outperformed conventional statistical methods. A summary of the limitations, such as lack of data availability or external validation of the framework, in the included studies, was also included. Conclusion: The rapid advancement of the AI framework and the exponential data generation in healthcare can be utilized and applied in clinical practices. The aid of AI can be instrumental in the treatment of DN.

2021 ◽  
pp. postgradmedj-2020-138864
Author(s):  
Sinéad Lydon ◽  
Emily O'Dowd ◽  
Chloe Walsh ◽  
Angela O'Dea ◽  
Dara Byrne ◽  
...  

Women are substantially underrepresented in senior and leadership positions in medicine and experience gendered challenges in their work settings. This systematic review aimed to synthesise research that has evaluated interventions for improving gender equity in medicine. English language electronic searches were conducted across MEDLINE, CINAHL, Academic Search Complete, PsycINFO and Web of Science. Reference list screening was also undertaken. Peer-reviewed studies published between 2000 and March 2020 that evaluated interventions to improve gender equity, or the experiences of women, in academic or clinical medicine were reviewed. Dual reviewer data extraction on setting, participants, type of intervention, measurement and outcomes was completed. Methodological rigour and strength of findings were evaluated. In total, 34 studies were included. Interventions were typically focused on equipping the woman (82.4%), that is, delivering professional development activities for women. Fewer focused on changing cultures (20.6%), ensuring equal opportunities (23.5%) or increasing the visibility or valuing of women (23.5%). Outcomes were largely positive (87.3%) but measurement typically relied on subjective, self-report data (69.1%). Few interventions were implemented in clinical settings (17.6%). Weak methodological rigour and a low strength of findings was observed. There has been a focus to-date on interventions which Equip the Woman. Interventions addressing systems and culture change require further research consideration. However, institutions cannot wait on high quality research evidence to emerge to take action on gender equity. Data collated suggest a number of recommendations pertaining to research on, and the implementation of, interventions to improve gender equity in academic and clinical settings.


2021 ◽  
Author(s):  
Mowafa Househ ◽  
Asma Alamgir ◽  
Yasmin Abdelaal ◽  
Hagar Hussein

BACKGROUND Artificial Intelligence technologies and big data have been increasingly used to enhance kidney transplant experts’ ability to make critical decisions and manage the care plan for their patients. OBJECTIVE To explore the use of AI technologies in the field of kidney transplantation as reported in the literature. METHODS Embase, CINAHL, PubMed and Google Scholar were used in the search. Backward reference list checking of included studies was also conducted. Study selection and data extraction was done independently by three reviewers. Data extracted was synthesized in a narrative approach. RESULTS Of 505 citations retrieved from the databases, 33 unique studies are included in this review. Artificial intelligence (AI) technologies in the included studies were used to help with diagnosis (n= 16), used as a prediction tool (n=15) and, also for supporting appropriate prescription for kidney transplant patients (n = 2). The population who benefited from the technique included patients who underwent kidney transplantation procedure (n = 24) and those who are potential candidate (n=6). The most prominent AI branch used in kidney transplantation care was machine learning with Random Forest (n=11) being the most used AI model, followed by Linear Regression (n=6). CONCLUSIONS Conclusion: AI is extensively being used in the field of kidney transplant. However, there is a gap in research on the limitation and obstacles associated with implementing AI technologies in kidney transplant. There is a need for more research to identify educational needs and standardized practice for clinicians who wish to apply AI technologies in critical transplantation-related decisions.


2021 ◽  
Author(s):  
Asma Alamgir ◽  
Osama Mousa 2nd ◽  
Zubair Shah 3rd

BACKGROUND Cardiac arrest is a life-threatening cessation of heart activity. Early prediction of cardiac arrest is important as it provides an opportunity to take the necessary measures to prevent or intervene during the onset. Artificial intelligence technologies and big data have been increasingly used to enhance the ability to predict and prepare for the patients at risk. OBJECTIVE This study aims to explore the use of AI technology in predicting cardiac arrest as reported in the literature. METHODS Scoping review was conducted in line with guidelines of PRISMA Extension for Scoping Review (PRISMA-ScR). Scopus, Science Direct, Embase, IEEE, and Google Scholar were searched to identify relevant studies. Backward reference list checking of included studies was also conducted. The study selection and data extraction were conducted independently by two reviewers. Data extracted from the included studies were synthesized narratively. RESULTS Out of 697 citations retrieved, 41 studies were included in the review, and 6 were added after backward citation checking. The included studies reported the use of AI in the prediction of cardiac arrest. We were able to classify the approach taken by the studies in three different categories - 26 studies predicted cardiac arrest by analyzing specific parameters or variables of the patients while 16 studies developed an AI-based warning system. The rest of the 5 studies focused on distinguishing high-risk cardiac arrest patients from patients, not at risk. 2 studies focused on the pediatric population, and the rest focused on adults (n=45). The majority of the studies used datasets with a size of less than 10,000 (n=32). Machine learning models were the most prominent branch of AI used in the prediction of cardiac arrest in the studies (n=38) and the most used algorithm belonged to the neural network (n=23). K-Fold cross-validation was the most used algorithm evaluation tool reported in the studies (n=24). CONCLUSIONS : AI is extensively being used to predict cardiac arrest in different patient settings. Technology is expected to play an integral role in changing cardiac medicine for the better. There is a need for more reviews to learn the obstacles of implementing AI technologies in the clinical setting. Moreover, research focusing on how to best provide clinicians support to understand, adapt and implement the technology in their practice is also required.


Author(s):  
Ryan Sadjadi

Diabetic retinopathy is the most common microvascular complication of diabetes mellitus and one of the leading causes of blindness globally. Due to the progressive nature of the disease, earlier detection and timely treatment can lead to substantial reductions in the incidence of irreversible vision-loss. Artificial intelligence (AI) screening systems have offered clinically acceptable and quicker results in detecting diabetic retinopathy from retinal fundus and optical coherence tomography (OCT) images. Thus, this systematic review and meta-analysis of relevant investigations was performed to document the performance of AI screening systems that were applied to fundus and OCT images of patients from diverse geographic locations including North America, Europe, Africa, Asia, and Australia. A systematic literature search on Medline, Global Health, and PubMed was performed and studies published between October 2015 and January 2020 were included. The search strategy was based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines, and AI-based investigations were mandatory for studies inclusion. The abstracts, titles, and full-texts of potentially eligible studies were screened against inclusion and exclusion criteria. Twenty-one studies were included in this systematic review; 18 met inclusion criteria for the meta-analysis. The pooled sensitivity of the evaluated AI screening systems in detecting diabetic retinopathy was 0.93 (95% CI: 0.92-0.94) and the specificity was 0.88 (95% CI: 0.86-0.89). The included studies detailed training and external validation datasets, criteria for diabetic retinopathy case ascertainment, imaging modalities, DR-grading scales, and compared AI results to those of human graders (e.g., ophthalmologists, retinal specialists, trained nurses, and other healthcare providers) as a reference standard. The findings of this study showed that the majority AI screening systems demonstrated clinically acceptable levels of sensitivity and specificity for detecting referable diabetic retinopathy from retinal fundus and OCT photographs. Further improvement depends on the continual development of novel algorithms with large and gradable sets of images for training and validation. If cost-effectiveness ratios can be optimized, AI can become a financially sustainable and clinically effective intervention that can be incorporated into the healthcare systems of low-to-middle income countries (LMICs) and geographically remote locations. Combining screening technologies with treatment interventions such as anti-VEGF therapy, acellular capillary laser treatment, and vitreoretinal surgery can lead to substantial reductions in the incidence of irreversible vision-loss due to proliferative diabetic retinopathy.


2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Brendan Kelly ◽  
Conor Judge ◽  
Stephanie M. Bollard ◽  
Simon M. Clifford ◽  
Gerard M. Healy ◽  
...  

Abstract Introduction There has been a recent explosion of research into the field of artificial intelligence as applied to clinical radiology with the advent of highly accurate computer vision technology. These studies, however, vary significantly in design and quality. While recent guidelines have been established to advise on ethics, data management and the potential directions of future research, systematic reviews of the entire field are lacking. We aim to investigate the use of artificial intelligence as applied to radiology, to identify the clinical questions being asked, which methodological approaches are applied to these questions and trends in use over time. Methods and analysis We will follow the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines and by the Cochrane Collaboration Handbook. We will perform a literature search through MEDLINE (Pubmed), and EMBASE, a detailed data extraction of trial characteristics and a narrative synthesis of the data. There will be no language restrictions. We will take a task-centred approach rather than focusing on modality or clinical subspecialty. Sub-group analysis will be performed by segmentation tasks, identification tasks, classification tasks, pegression/prediction tasks as well as a sub-analysis for paediatric patients. Ethics and dissemination Ethical approval will not be required for this study, as data will be obtained from publicly available clinical trials. We will disseminate our results in a peer-reviewed publication. Registration number PROSPERO: CRD42020154790


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Iacopo Vagliano ◽  
Nicholas Chesnaye ◽  
Jan Hendrik Leopold ◽  
Kitty J Jager ◽  
Ameen Abu Hanna ◽  
...  

Abstract Background and Aims Acute kidney injury (AKI) has a substantial impact on global disease burden of Chronic Kidney Disease. To assist physicians with the timely diagnosis of AKI, several prognostic models have been developed to improve early recognition across various patient populations with varying degrees of predictive performance. In the prediction of AKI, machine learning (ML) techniques have been demonstrated to improve on the predictive ability of existing models that rely on more conventional statistical methods. ML is a broad term which refers to various types of models: Parametric models, such as linear or logistic regression use a pre-specified model form which is believed to fit the data, and its parameters are estimated. Non-parametric models, such as decision trees, random forests, and neural networks may have varying complexity (e.g. the depth of a classification tree model) based on the data. Deep learning neural network models exploit temporal or spatial arrangements in the data to deal with complex predictors. Given the rapid growth and development of ML methods and models for AKI prediction over the past years, in this systematic review, we aim to appraise the current state-of-the-art regarding ML models for the prediction of AKI. To this end, we focus on model performance, model development methods, model evaluation, and methodological limitations. Method We searched the PubMed and ArXiv digital libraries, and selected studies that develop or validate an AKI-related multivariable ML prediction model. We extracted data using a data extraction form based on the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) and CHARMS (critical appraisal and data extraction for systematic reviews of prediction modelling studies) checklists. Results Overall, 2,875 titles were screened and thirty-four studies were included. Of those, thirteen studies focussed on intensive care, for which the US derived MIMIC dataset was commonly used; thirty-one studies both developed and validated a model; twenty-one studies used single-centre data. Non-parametric ML methods were used more often than regression and deep learning. Random forests was the most popular method, and often performed best in model comparisons. Deep learning was typically used (and also effective) when complex features were included (e.g., with text or time series). Internal validation was often applied, and the performance of ML models was usually compared against logistic regression. However, the simple training/test split was often used, which does not account for the variability of the training and test samples. Calibration, external validation, and interpretability of results were rarely considered. Comparisons of model performance against medical scores or clinicians were also rare. Reproducibility was limited, as data and code were usually unavailable. Conclusion There is an increasing number of ML models for AKI, which are mostly developed in the intensive care environment largely due to the availability of the MIMIC dataset. Most studies are single-centre, and lack a prospective design. More complex models based on deep learning are emerging, with the potential to improve predictions for complex data, such as time-series, but with the disadvantage of being less interpretable. Future studies should pay attention to using calibration measures, external validation, and on improving model interpretability, in order to improve uptake in clinical practice. Finally, sharing data and code could improve reproducibility of study findings.


BMJ Open ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. e044687
Author(s):  
Lauren S. Peetluk ◽  
Felipe M. Ridolfi ◽  
Peter F. Rebeiro ◽  
Dandan Liu ◽  
Valeria C Rolla ◽  
...  

ObjectiveTo systematically review and critically evaluate prediction models developed to predict tuberculosis (TB) treatment outcomes among adults with pulmonary TB.DesignSystematic review.Data sourcesPubMed, Embase, Web of Science and Google Scholar were searched for studies published from 1 January 1995 to 9 January 2020.Study selection and data extractionStudies that developed a model to predict pulmonary TB treatment outcomes were included. Study screening, data extraction and quality assessment were conducted independently by two reviewers. Study quality was evaluated using the Prediction model Risk Of Bias Assessment Tool. Data were synthesised with narrative review and in tables and figures.Results14 739 articles were identified, 536 underwent full-text review and 33 studies presenting 37 prediction models were included. Model outcomes included death (n=16, 43%), treatment failure (n=6, 16%), default (n=6, 16%) or a composite outcome (n=9, 25%). Most models (n=30, 81%) measured discrimination (median c-statistic=0.75; IQR: 0.68–0.84), and 17 (46%) reported calibration, often the Hosmer-Lemeshow test (n=13). Nineteen (51%) models were internally validated, and six (16%) were externally validated. Eighteen (54%) studies mentioned missing data, and of those, half (n=9) used complete case analysis. The most common predictors included age, sex, extrapulmonary TB, body mass index, chest X-ray results, previous TB and HIV. Risk of bias varied across studies, but all studies had high risk of bias in their analysis.ConclusionsTB outcome prediction models are heterogeneous with disparate outcome definitions, predictors and methodology. We do not recommend applying any in clinical settings without external validation, and encourage future researchers adhere to guidelines for developing and reporting of prediction models.Trial registrationThe study was registered on the international prospective register of systematic reviews PROSPERO (CRD42020155782)


2021 ◽  
Vol 29 (Supplement_1) ◽  
pp. i18-i18
Author(s):  
N Hassan ◽  
R Slight ◽  
D Weiand ◽  
A Vellinga ◽  
G Morgan ◽  
...  

Abstract Introduction Sepsis is a life-threatening condition that is associated with increased mortality. Artificial intelligence tools can inform clinical decision making by flagging patients who may be at risk of developing infection and subsequent sepsis and assist clinicians with their care management. Aim To identify the optimal set of predictors used to train machine learning algorithms to predict the likelihood of an infection and subsequent sepsis and inform clinical decision making. Methods This systematic review was registered in PROSPERO database (CRD42020158685). We searched 3 large databases: Medline, Cumulative Index of Nursing and Allied Health Literature, and Embase, using appropriate search terms. We included quantitative primary research studies that focused on sepsis prediction associated with bacterial infection in adult population (>18 years) in all care settings, which included data on predictors to develop machine learning algorithms. The timeframe of the search was 1st January 2000 till the 25th November 2019. Data extraction was performed using a data extraction sheet, and a narrative synthesis of eligible studies was undertaken. Narrative analysis was used to arrange the data into key areas, and compare and contrast between the content of included studies. Quality assessment was performed using Newcastle-Ottawa Quality Assessment scale, which was used to evaluate the quality of non-randomized studies. Bias was not assessed due to the non-randomised nature of the included studies. Results Fifteen articles met our inclusion criteria (Figure 1). We identified 194 predictors that were used to train machine learning algorithms to predict infection and subsequent sepsis, with 13 predictors used on average across all included studies. The most significant predictors included age, gender, smoking, alcohol intake, heart rate, blood pressure, lactate level, cardiovascular disease, endocrine disease, cancer, chronic kidney disease (eGFR<60ml/min), white blood cell count, liver dysfunction, surgical approach (open or minimally invasive), and pre-operative haematocrit < 30%. These predictors were used for the development of all the algorithms in the fifteen articles. All included studies used artificial intelligence techniques to predict the likelihood of sepsis, with average sensitivity 77.5±19.27, and average specificity 69.45±21.25. Conclusion The type of predictors used were found to influence the predictive power and predictive timeframe of the developed machine learning algorithm. Two strengths of our review were that we included studies published since the first definition of sepsis was published in 2001, and identified factors that can improve the predictive ability of algorithms. However, we note that the included studies had some limitations, with three studies not validating the models that they developed, and many tools limited by either their reduced specificity or sensitivity or both. This work has important implications for practice, as predicting the likelihood of sepsis can help inform the management of patients and concentrate finite resources to those patients who are most at risk. Producing a set of predictors can also guide future studies in developing more sensitive and specific algorithms with increased predictive time window to allow for preventive clinical measures.


Author(s):  
Onur Dogan ◽  
Sanju Tiwari ◽  
M. A. Jabbar ◽  
Shankru Guggari

AbstractA pandemic disease, COVID-19, has caused trouble worldwide by infecting millions of people. The studies that apply artificial intelligence (AI) and machine learning (ML) methods for various purposes against the COVID-19 outbreak have increased because of their significant advantages. Although AI/ML applications provide satisfactory solutions to COVID-19 disease, these solutions can have a wide diversity. This increase in the number of AI/ML studies and diversity in solutions can confuse deciding which AI/ML technique is suitable for which COVID-19 purposes. Because there is no comprehensive review study, this study systematically analyzes and summarizes related studies. A research methodology has been proposed to conduct the systematic literature review for framing the research questions, searching criteria and relevant data extraction. Finally, 264 studies were taken into account after following inclusion and exclusion criteria. This research can be regarded as a key element for epidemic and transmission prediction, diagnosis and detection, and drug/vaccine development. Six research questions are explored with 50 AI/ML approaches in COVID-19, 8 AI/ML methods for patient outcome prediction, 14 AI/ML techniques in disease predictions, along with five AI/ML methods for risk assessment of COVID-19. It also covers AI/ML method in drug development, vaccines for COVID-19, models in COVID-19, datasets and their usage and dataset applications with AI/ML.


2020 ◽  
Vol 22 (4) ◽  
pp. 469
Author(s):  
Mihaela Grigore ◽  
Razvan Mihai Popovici ◽  
Dumitru Gafitanu ◽  
Loredana Himiniuc ◽  
Mara Murarasu ◽  
...  

Adnexal masses are common, yet challenging, in gynecological practice. Making the differential diagnosis between their benign and malignant condition is essential for optimal surgical management, but reliable pre-surgical differentiation is sometimes difficult using clinical features, ultrasound examination, or tumor markers alone. A possible way to improve the diagnosis is using artificial intelligence (AI) or logistic models developed based on compiling and processing clinical, ultrasound, and tumor marker data together. Ample research has already been conducted in this regard that medical practitioners could benefit from. In this systematic review, we present logistic models and methods using AI, chosen based on their demonstrated high performance in clinical practice. Although some external validation of these models has been performed, further prospective studies are needed in order to select the best model or to create a new, more efficient, one for the pre-surgical evaluation of ovarian masses. 


Sign in / Sign up

Export Citation Format

Share Document